[Acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD)]
DOI:
https://doi.org/10.7175/cmi.v11i2.1308Keywords:
COPD, Exacerbations, Bronchitis, BronchodilatorsAbstract
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. Acute exacerbations of COPD (AECOPD) are important events in the natural history of this condition because they negatively impact health status, rate of hospitalization, disease progression, and mortality.
Viral and/or bacterial infections are the main cause of exacerbations. The treatments include systemic corticosteroids, bronchodilators, anticholinergics and/or short- or long-acting β2-agonists, and antibiotics in case of bacterial infections. In some cases, oxygen-therapy is indicated.
This article focuses on several aspects of AECOPD, including epidemiology, diagnostic approach, i.e. investigations and management of AECOPD.
References
Buist AS, McBurnei MA, Vollmer VM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007; 370: 741-50; https://doi.org/10.1016/S0140-6736(07)61377-4
Hagstad S, Ekerljung L, Lindberg A, et al. COPD among non smokers-Report from the Obstructive Lung Disease in Northern Sweden (OLIN) studies. Respiratory Medicine 2012; 106: 980-8; https://doi.org/10.1016/j.rmed.2012.03.010
Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health 2015; 5: 020415; https://doi.org/10.7189/jogh.05.020415
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD, 2017. Disponibile all’indirizzo http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/ (ultimo accesso giugno 2017)
Pellegrino R, Brusasco V, Viegi G, et al. Definition of COPD based on evidence or opinion? Eur Resp J 2008; 31: 681-2; https://doi.org/10.1183/09031936.00154307
Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007; 370: 786-96; https://doi.org/10.1016/S0140-6736(07)61382-8
Hoogendoorn M, Feenstra TL, Hoogenveen RT, et al. Association between lung function and exacerbation frequency in patients with COPD. COPD 2010; 5: 435-44; https://doi.org/10.2147/COPD.S13826
Cao Z, Ong KC, Eng P, et al. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006; 11: 188-95; https://doi.org/10.1111/j.1440-1843.2006.00819.x
Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-38; https://doi.org/10.1056/NEJMoa0909883
Ansueto A, Sethi S, Martinez FJ. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4: 554-64
Donaldson GC, Seemungal TAR, Bhomik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-52; https://doi.org/10.1136/thorax.57.10.847
Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease a systematic review and meta-analysis. Ann Am Thorac Soc 2013; 10: 81-9; https://doi.org/10.1513/AnnalsATS.201208-043OC
National Institute for Health and Care Excellence (NICE). Chronic Obstructive Pulmonary Disease 2010. Disponibile all’indirizzo https://www.nice.org.uk/guidance/qs10 (ultimo accesso giugno 2017)
O’Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 update. Can Respir J 2007; 14(Suppl B): 5B-32B; https://doi.org/10.1155/2007/830570; https://doi.org/10.1155/2007/926421
Anthonisen NR, Manfreda J, Warren CPW, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Inter Med 1987; 106: 196-204; https://doi.org/10.7326/0003-4819-106-2-196
Bandi V, Jakubowycs M, Kynion C, et al. Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol Med Microbiol 2003; 37: 69-75; https://doi.org/10.1016/S0928-8244(03)00100-7
Wedzicha JA. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1: 115-20; https://doi.org/10.1513/pats.2306030
Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 2355-65; https://doi.org/10.1056/NEJMra0800353
Lode H, Allewelt M, Balk S, et al. A prediction model for bacterial etiology in acute exacerbations of COPD. Infection 2007; 35: 143-9; https://doi.org/10.1007/s15010-007-6078-z
Rodriguez-Roisin R. COPD exacerbations. Thorax 2006; 61; 535-44; https://doi.org/10.1136/thx.2005.041863
Rennard SI. Treatment of stable chronic obstructive pulmonary disease. Lancet 2004; 364: 791-802; https://doi.org/10.1016/S0140-6736(04)16941-9
Roy SR, Milgron H. Management of the acute exacerbation of asthma. J Asthma 2003; 40: 593-604; https://doi.org/10.1081/JAS-120018776
Aaron SD. The use of ipratropium bromide for the management of acute asthma exacerbation in adults and children: A systematic review. J Asthma 2001; 38: 521-30; https://doi.org/10.1081/JAS-100107116
Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006; (2): CD000052; https://doi.org/10.1002/14651858.cd000052.pub2
Bach PB, Brown C, Gelfland SE, et al. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern 2001; 134: 600-20; https://doi.org/10.7326/0003-4819-134-7-200104030-00016
Wood-Baker RR, Gison PG, Hannay M, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;(1): CD001288
Leuppi JD, Schueltz P, Bingisser R, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013; 309: 2223-31; https://doi.org/10.1001/jama.2013.5023
Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest 2008; 133: 756-66; http://doi.org/10.1378/chest.07-1207
Ram FS, Rodriguez-Roisin R, Granados-Navarrete A, et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; (2): CD004403; https://doi.org/10.1002/14651858.cd004403.pub2
Dimopoulos G, Siempos II, Korbila IP, et al. Comparison of first-line antibiotics with second-line antibiotics for acute exacerbations of chronic bronchitis: a metanalysis of randomized controlled trials. Chest 2007; 132: 447-55; https://doi.org/10.1378/chest.07-0149
Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Int Med 1980; 91: 391-8
Medical Research Council. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working Party. Lancet 1981; 1: 681-6
Yeow M, Santanilla JI. Non invasive positive pressure ventilation in the emergency department. Emerg Med Clin N Am 2008; 26: 835-47; https://doi.org/10.1016/j.emc.2008.04.005
Keenan SP, Sinuff T, Cook DJ, et al. Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positive-pressure ventilation? A systematic review of the literature. Ann Intern Med 2003; 138: 861-70; https://doi.org/10.7326/0003-4819-138-11-200306030-00007
Ram FS, Picot J, Lightowler J, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004;(3):CD004104; https://doi.org/10.1002/14651858.cd004104.pub3
Conti G, Antonelli M, Navalesi P, et al. Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial. Intensive Care Med 2002; 28: 1701-7; https://doi.org/10.1007/s00134-002-1478-0
Merlani PG, Pasquina P, Granier JM, et al. Factors associated with failure of noninvasive positive pressure ventilation in the emergency department. Acad Emerg Med 2005; 12: 1206-15; https://doi.org/10.1111/j.1553-2712.2005.tb01499.x
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)